The biopreservation market is projected to grow significantly, reaching a value of $10.7 billion by 2032, expanding at a compound annual growth rate (CAGR) of 18.2% from its 2025 valuation of $3.3 billion. This growth is driven by advancements in cryopreservation technologies, increased biotechnology and pharmaceutical research, and the rising demand for regenerative medicine, cell therapies, vaccines, and immunotherapies.
Biopreservation plays a crucial role in healthcare and life sciences, ensuring the viability, stability, and functionality of biological materials such as cells, tissues, and organs. This sector is witnessing substantial investment from governments, research institutions, biotechnology companies, and healthcare organizations, which is accelerating the development and adoption of preservation equipment, specialized media, and laboratory information management systems.
Key Market Trends and Growth Drivers
Within the biopreservation market, regenerative medicine and biobanking are two of the most significant application areas. The preservation of stem cells and the production of cell-based therapies necessitate stringent storage, transport, and handling processes. Compliance with Good Manufacturing Practice (GMP) requirements and other regulatory standards is essential throughout the product lifecycle.
Cryogenic and hypothermic storage technologies are central to preserving biological materials by limiting metabolic activity and maintaining cellular integrity. Innovations in cryopreservation protocols, storage equipment, monitoring systems, and preservation media are enhancing post-storage recovery rates and supporting the commercialization of advanced therapies.
The market is also expanding due to the increasing prevalence of chronic diseases and the need for new therapeutic solutions. Rising research and development activity in drug discovery, precision medicine, vaccine production, and enzyme technology is boosting demand for reliable biological sample preservation. Additionally, the global expansion of biobanks is creating further requirements for scalable storage infrastructure, sample traceability, quality control, and long-term data management.
Regulatory oversight is another significant influence on the market. Biologically derived therapeutic products must adhere to rigorous standards for safety, consistency, and clinical effectiveness. This drives healthcare and life sciences organizations to invest in validated biopreservation solutions that ensure sample quality throughout collection, processing, storage, distribution, and administration.
Market Segmentation and Regional Outlook
The biopreservation market is segmented into equipment, media, and laboratory information management systems. Key application areas include biobanking, regenerative medicine, and drug discovery, with end-users spanning life sciences and healthcare organizations, research laboratories, and other stakeholders.
The equipment segment is expected to reach $5.3 billion by 2032, growing at a CAGR of 19.9%. The media segment is projected to grow at a CAGR of 17.5%, reflecting increased demand for formulations that enhance cell viability, stability, and recovery.
Regionally, the United States biopreservation market was valued at approximately $904 million in 2025. China is forecast to expand at a CAGR of 23.7%, reaching $2.5 billion by 2032. The report also evaluates market developments across Canada, Japan, Germany, France, Italy, the United Kingdom, Spain, Russia, Australia, India, South Korea, Latin America, the Middle East, and Africa.
Comprehensive Market Analysis
The “Biopreservation – Global Strategic Business Report” provides an independent analysis of annual market sales and forecasts from 2025 through 2032. It examines market size, segment performance, regional opportunities, competitive conditions, emerging technologies, growth drivers, and potential restraints. This analysis aids organizations in assessing investment priorities, identifying revenue opportunities, benchmarking competitors, and strengthening strategic planning.
Key questions addressed in the report include the evolution of the global biopreservation market through 2032, the technologies, applications, and end-use sectors offering the strongest growth potential, and the factors driving or restraining market expansion. The report also explores regional and segment share changes and identifies companies influencing the competitive landscape.
Featured companies in the report include Atlanta Biologicals, Inc., BioCision, LLC, BioGenix, LLC, BioLife Solutions, Inc., Biomatrica, Inc., LabVantage Solutions, Inc., Panasonic Corporation, Qiagen, Inc., Thermo Fisher Scientific, Inc., and VWR International LLC.
The report incorporates insights from domain experts across industry, enterprise, and academia, providing context beyond conventional published research. It tracks early market signals from expert discussions, corporate activity, conference sessions, keynote presentations, panel discussions, company disclosures, annual reports, institutional publications, and other validated sources.
These insights are synthesized to identify strategic market direction, important technology developments, competitive priorities, and factors likely to influence future demand. The analysis extends beyond global market estimates to assess company activity and regional competitive structures. Where analytically relevant, market share is examined across major geographies to reflect differences in local demand, regulation, investment, and industry participation.
Footnotes:
- The biopreservation market is projected to grow from $3.3 billion in 2025 to $10.7 billion by 2032. Source.
- The equipment segment of the biopreservation market is forecast to reach $5.3 billion by 2032. Source.
- China’s biopreservation market is expected to expand at a CAGR of 23.7% by 2032. Source.
Featured Image: Megapixl @ Noipornpan
